Skip to main content

Peer Review reports

From: Impact of a reimbursement policy change on treatment with erenumab in migraine – a real-world experience from Germany

Original Submission
25 Sep 2023 Submitted Original manuscript
28 Sep 2023 Reviewed Reviewer Report - Luigi Alberto Pini
10 Oct 2023 Reviewed Reviewer Report
18 Oct 2023 Author responded Author comments - Bianca Raffaelli
Resubmission - Version 2
18 Oct 2023 Submitted Manuscript version 2
Publishing
18 Oct 2023 Editorially accepted
30 Oct 2023 Article published 10.1186/s10194-023-01682-2

You can find further information about peer review here.

Back to article page